WASHINGTON — Danaher Corporation (NYSE: DHR) (the “Company”) and Integrated DNA Technologies (“IDT”) announced today that Danaher has entered into a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics. IDT’s primary business is the manufacturing of […]

PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s enterprise software platform, the Clinical Genomics WorkSpace (CGW). “Since PierianDx was first founded in 2014, our mission has always been to enable precision medicine for our customers,” said PierianDx founder and CEO […]

Highlights: Acquisition advances Agilent’s growth strategy. Highly attractive business with robust growth track record and prospects. Combination strengthens customer value proposition with complementary technologies and solutions. Opportunity to accelerate expansion into adjacent businesses. SANTA CLARA, Calif. Agilent Technologies, Inc. (NYSE: A) today announced that it has signed a definitive agreement to acquire privately-held Advanced Analytical Technologies, Inc. (AATI), a provider of capillary electrophoresis-based (CE) […]

El Segundo, CA – BioDiscovery, Inc., a leader in innovative genomic data analysis software solutions announced today that BioDiscovery and Thermo Fisher Scientific have formed a partnership creating an assay plus analysis cancer research package with Nexus Express for OncoScan™ software for Thermo Fisher’s Cancer Research portfolio. BioDiscovery initially began the partnership three years ago with Affymetrix, […]

New Polymerase and Software Releases Improve Structural Variant Detection, Targeted Sequencing and RNA Sequencing Applications MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced a new version of Sequel® Software (V5.1) and a new polymerase. Combined, these enhancements increase throughput and the overall performance of Single Molecule, Real-Time (SMRT®) Sequencing […]

VANCOUVER, BRITISH COLUMBIA – STEMCELL Technologies has signed an exclusive license with Indiana University Innovation and Commercialization Office for patented rights to groundbreaking inner ear organoid technologies. The inner ear contains organs responsible for detecting sounds and maintaining balance, both of which are mediated by a sensory cell called the hair cell due to its specialized protrusions resembling tiny […]

– WuXi NextCODE’s massively scalable genomics database management system and clinical and research applications will be available to Google Cloud Platform users – Google Cloud BigQuery, the open source DeepVariant and other tools will be integrated for use with the WuXi NextCODE platform – The companies plan to work on additional tools, capabilities and APIs […]

Houston, TX and Emeryville, CA – The University of Texas MD Anderson Cancer Center and Berkeley Lights, Inc. today announced the launch of Optera Therapeutics Corp, a biopharmaceutical company developing cell therapies with scalable manufacturing solutions for cancer. Cell-based immunotherapies where patients are treated with their own immune cells, such as chimeric antigen receptor (CAR-T) and […]

TGR BioSciences is proud to announce the global availability of Alpha Terbium SureFire® Ultra™ (TBSU) assay kits. These new kits can be easily combined with existing AlphaLISA® SureFire Ultra (ALSU) kits to provide high throughput capability of multiplexed phosphoprotein detection in a homogeneous assay format. The new kits combine PerkinElmer, Inc.’s highly sensitive and homogeneous Alpha (Amplified Luminescent Proximity Homogenous […]

Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced its subsidiaries Innova Biosciences, Expedeon Holdings, and C.B.S. Scientific have united as Expedeon, effective 1 March 2018. The corporate rebranding follows the latest acquisition of Innova Biosciences by SYGNIS AG in June 2017. SYGNIS AG will continue to serve as […]